Document Detail


Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study.
MedLine Citation:
PMID:  18475164     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Whether left bundle branch block is associated with cardiovascular events in hypertension with electrocardiographic left ventricular hypertrophy is unknown. METHODS: Hypertensive patients with electrocardiographic-left ventricular hypertrophy were randomized to losartan-based or atenolol-based treatment and followed for 4.8 years in the losartan intervention for endpoint reduction in hypertension study. Cox regression models controlling for significant covariates assessed the association of left bundle branch block with cardiovascular events. RESULTS: At baseline, 564 patients had left bundle branch block and 8567 patients did not. Left bundle branch block was associated with higher heart rate, electrocardiographic-left ventricular hypertrophy, and prior cardiovascular disease (all P < 0.005). In univariate Cox regression analysis, left bundle branch block was not associated with the composite endpoint, stroke, or myocardial infarction (all P > 0.05), and was associated with cardiovascular (8.3 versus 4.5%, P < 0.001) and all-cause mortality (12.1 versus 8.6%, P < 0.005). After adjusting for significant covariates Cox regression analyses showed that left bundle branch block was independently associated with 1.6-fold more cardiovascular death (95% confidence interval 1.12-2.27, P < 0.05), 1.7 fold more hospitalization for heart failure (95% confidence interval 1.15-2.56, P < 0.01), 3.5 fold more cardiovascular death within 1 h (95% confidence interval 1.89-6.63, P < 0.001), and 3.4 fold more cardiovascular death within 24 h (95% confidence interval 1.83-6.35, P < 0.001). CONCLUSION: In hypertension with electrocardiographic-left ventricular hypertrophy, left bundle branch block identifies patients at increased risk of cardiovascular mortality, sudden cardiovascular death, and heart failure.
Authors:
Zhibin Li; Björn Dahlöf; Peter M Okin; Sverre E Kjeldsen; Kristian Wachtell; Hans Ibsen; Markku S Nieminen; Sverker Jern; Richard B Devereux
Related Documents :
6883644 - Reduced space constant in slowly conducting regions of chronically infarcted canine myo...
1235334 - Intraventricular blocks in acute myocardial infarction.
15907824 - Knockout of the neural and heart expressed gene hf-1b results in apical deficits of ven...
837514 - De subitaneis mortibus. xxiii. rheumatoid arthritis and ankylosing spondylitis.
18804744 - Prevalence of different gadolinium enhancement patterns in patients after heart transpl...
1715124 - Effects of enflurane on inducibility of ventricular tachycardia.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of hypertension     Volume:  26     ISSN:  0263-6352     ISO Abbreviation:  J. Hypertens.     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-05-13     Completed Date:  2008-07-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8306882     Medline TA:  J Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  1244-9     Citation Subset:  IM    
Affiliation:
Department of Medicine, Weill Cornell Medical College, New York, NY 10021, USA.
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00338260
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Antihypertensive Agents / therapeutic use
Atenolol / therapeutic use
Bundle-Branch Block / complications,  diagnosis,  mortality*
Electrocardiography
Female
Humans
Hypertension / complications,  drug therapy,  mortality*
Hypertrophy, Left Ventricular / complications,  drug therapy,  mortality*
Losartan / therapeutic use
Male
Middle Aged
Prognosis
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 114798-26-4/Losartan; 29122-68-7/Atenolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Aortic stiffness and the balance between cardiac oxygen supply and demand: the Rotterdam Study.
Next Document:  Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlor...